Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01716546 | Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer | terminated | Phase 1 / Phase 2 | 51 | Hellenic Oncology Research GroupOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT01088204 | Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer(COACT_1001) | unknown | Phase 2 | 204 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 7, 2015 |
| clinicaltrials |
| NCT01130337 | A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer | completed | Phase 2 | 36 | Hoffmann-La RocheINDUSTRY | 1 | Oct 1, 2015 | clinicaltrials |
| NCT02549911 | HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis | unknown | Phase 2 | 40 | Zhejiang Cancer HospitalOTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT00620607 | huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas | withdrawn | Phase 2 | 0 | ImmunoGen, Inc.INDUSTRY | 1 | Aug 26, 2015 | clinicaltrials |
| NCT02525237 | Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 30 | Qingdao Municipal HospitalOTHER | 0 | Aug 17, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02521649 | Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer | completed | Phase 2 | 52 | Cancer Advances Inc.INDUSTRY | 0 | Aug 13, 2015 | clinicaltrials |
| NCT02518529 | Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients | completed | Phase 2 | 41 | Cancer Advances Inc.INDUSTRY | 0 | Aug 10, 2015 | clinicaltrials |
| NCT02504229 | DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment | unknown | Phase 2 | 80 | Beijing Biohealthcare Biotechnology Co.,LtdINDUSTRY | 1 | Jul 21, 2015 | clinicaltrials |
| NCT00674167 | The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma | unknown | Phase 2 | 21 | National University Hospital, SingaporeOTHER | 1 | Jun 12, 2015 | clinicaltrials |
| NCT02450032 | Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer(GC5) | completed | Phase 2 | 12 | Cancer Advances Inc.INDUSTRY | 1 | May 21, 2015 | clinicaltrials |
| NCT01136031 | Paclitaxel and Irinotecan in Advanced Gastric Cancer(TI-2ndAGC) | completed | Phase 1 / Phase 2 | 42 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00477711 | A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer(EXTRA) | completed | Phase 2 | 41 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00842491 | Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer | completed | Phase 2 | 45 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01336062 | Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 19 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01679340 | A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery | unknown | Phase 2 | 160 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT02413476 | Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy | unknown | Phase 2 / Phase 3 | 120 | wei boOTHER | 0 | May 19, 2015 | clinicaltrials |
| NCT00718913 | Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer | completed | Phase 2 | 40 | Hellenic Oncology Research GroupOTHER | 1 | May 18, 2015 | clinicaltrials |
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 18, 2015 | clinicaltrials |
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 43 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 0 | May 13, 2015 | clinicaltrials |
| NCT00084617 | Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 1, 2015 | clinicaltrials |
| NCT02423278 | The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer | unknown | Phase 2 / Phase 3 | 200 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT00226811 | An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy | completed | Phase 2 | 78 | PfizerINDUSTRY | 7 | Mar 30, 2015 | clinicaltrials |
| NCT01980407 | Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 49 | Jilin Provincial Tumor HospitalOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02370849 | Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma | completed | Phase 2 | 2 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT00447330 | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma(XAGastric) | completed | Phase 2 | 60 | Duke UniversityOTHER | 1 | Feb 13, 2015 | clinicaltrials |
| NCT00539968 | A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) | terminated | Phase 1 / Phase 2 | 5 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 5, 2015 | clinicaltrials |
| NCT01674959 | Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 5, 2015 | clinicaltrials |
| NCT00673673 | FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer | completed | Phase 2 | 39 | Yale UniversityOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01874938 | A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | completed | Phase 2 | 15 | Eli Lilly and CompanyINDUSTRY | 2 | Jan 16, 2015 | clinicaltrials |
| NCT01614522 | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | completed | Phase 2 | 24 | ASLAN PharmaceuticalsOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT00683787 | Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | terminated | Phase 2 | 8 | Roswell Park Cancer InstituteOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01158287 | Sorafenib. ICORG 06-41, V4 | completed | Phase 2 | 54 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT02311595 | A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection | unknown | Phase 2 | 67 | Samsung Medical CenterOTHER | 0 | Dec 8, 2014 | clinicaltrials |
| NCT01531452 | The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer | completed | Phase 2 | 43 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT00374985 | Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction | completed | Phase 1 / Phase 2 | 25 | Johannes Gutenberg University MainzOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00253370 | Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Nov 24, 2014 | clinicaltrials |
| NCT02296658 | A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer | unknown | Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02291211 | S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis | unknown | Phase 2 | 60 | Tang-Du HospitalOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT01497964 | Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy(GASTANA) | completed | Phase 1 / Phase 2 | 16 | SanofiINDUSTRY | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer(DaeMon) | completed | Phase 2 | 39 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT00343239 | Docetaxel in Locally Advanced Gastric Adenocarcinoma(NEOTAX) | completed | Phase 2 | 59 | SanofiINDUSTRY | 1 | Nov 4, 2014 | clinicaltrials |
| NCT01138904 | FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC) | completed | Phase 2 | 80 | Dong-A University HospitalOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT01246960 | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | completed | Phase 2 | 168 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00006389 | Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Oct 1, 2014 | clinicaltrials |
| NCT02250209 | T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy | unknown | Phase 2 | 40 | Chinese PLA General HospitalOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT02233712 | Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.(GC3) | completed | Phase 2 | 33 | Cancer Advances Inc.INDUSTRY | 0 | Sep 8, 2014 | clinicaltrials |
| NCT00042510 | Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer | completed | Phase 2 | 103 | Cancer Advances Inc.INDUSTRY | 0 | Aug 28, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Oct 8, 2015source: clinicaltrials